FOSUN HEALTH Logo

Ovarian Cancer FAQ

catalogue

Ovarian Cancer FAQ

Ovarian Cancer FAQ

The conceptual questions — types, stages, why surgery or chemotherapy first — are answered on the other pages of this guide. This page covers what patients actually need to organise: what treatment costs relative to home, how long you stay, what to bring, and what life after treatment looks like.

What treatment costs

The network's published position: treatment in China runs at roughly 30%–50% of the equivalent treatment in Europe or the US. The range is honest rather than exact, because what you pay depends on the route — a fertility-sparing stage I operation, a full debulking with bowel resection, and a six-cycle chemotherapy course with maintenance are different orders of cost — and on the drug component of maintenance therapy.

What the network commits to is the structure: a written, itemised estimate after your records are reviewed, before you travel. No figure quoted on a website or by phone replaces that estimate, because it is built on the actual planned route — and the route, as this guide sets out, depends on the resectability assessment and the genotype. Ask for the estimate in writing and hold the plan to it.

How long you stay

Length of stay follows the route. Debulking surgery means one to two weeks in hospital, with recovery before flying measured in several weeks and discussed case by case — longer where bowel was resected. Chemotherapy is an outpatient course: six cycles of carboplatin–paclitaxel at three-week intervals, meaning patients base themselves near the hospital for roughly four to five months, which the international service helps arrange. PARP maintenance is tablets at home, with remote follow-up through the international service.

The planning point: the surgery-first and chemotherapy-first routes have different calendars from each other, and the maintenance phase is where most of the stay-after-treatment happens — at home. The file is reviewed before flights are booked, whichever route applies.

Medicines to bring

Bring your regular medicines in original packaging with a doctor's letter, in quantities covering the first weeks. Three points specific to this disease: anti-sickness and pain medication you already rely on, since prescriptions are re-established locally rather than assumed; hormone therapy, if you take it, flagged in advance because surgical menopause changes the conversation; and anything taken for a genetic condition or prior cancer, documented with doses. Anything infusion-based — chemotherapy, bevacizumab — and the PARP maintenance tablets are provided at the hospital and need not travel with you.

Records to prepare

The file that lets a gynaecological oncology MDT answer within 48 hours contains five items:

  • The imaging itself — pelvic ultrasound report plus the CT discs or links, not only reports
  • CA-125 (and HE4) values over time, as a trend rather than a single number
  • The pathology or cytology report, and the paraffin blocks where tissue exists
  • Genetic results — germline BRCA, tumour BRCA/HRD — or the agreement to test here
  • Anything already treated: operation notes, chemotherapy cycles and dates, maintenance started

The most commonly missing items are the imaging itself and the paraffin blocks, and they are the two the resectability assessment and the genotype question turn on. Reports without discs allow a provisional view; they do not allow a sequence.

Insurance and direct billing

The network holds direct-billing relationships with more than 55 international insurers, which means eligible policies are settled between insurer and hospital rather than by the patient upfront. What to do before travelling: confirm with your insurer that treatment at the specific hospital is covered, ask whether pre-authorisation is required for surgery or chemotherapy, and bring the policy number and authorisation letter. The international service checks eligibility in advance of arrival, not after it. Out-of-pocket patients receive the itemised estimate described above and settle against it directly.

Life after treatment

Follow-up after ovarian cancer treatment has two registers. For epithelial disease in remission: CA-125 trends, examinations and imaging on a defined schedule, with maintenance therapy continued and monitored — blood counts and clinic reviews for PARP inhibitors, blood pressure checks for bevacizumab. For women after risk-reducing or fertility-sparing surgery: the menopause and hormone questions managed deliberately, and fertility follow-up with obstetric input where the uterus remains.

The second register is ordinary life: work, travel and exercise resume on timelines that depend on the route, and the follow-up calendar is built around them rather than the reverse. Ask for the follow-up plan and the maintenance schedule in writing before you fly home — for a treatment whose longest phase is tablets at home, that written plan is the treatment.

Eating during treatment

Nutrition through chemotherapy is planned before the first cycle, because the regimen suppresses appetite and the disease itself causes early satiety — a combination that loses weight quietly. The working principles: small frequent meals rather than three large ones, protein at every meal, and weight recorded weekly so the trend is visible; mouth care and taste changes are managed with the dietitian rather than endured. A dietitian sees patients on treatment at this network as a matter of course, and adjustments are made at each cycle review rather than after problems accumulate. After treatment, no special diet is required — the goal is a return to ordinary, adequate eating, monitored through the follow-up weights.

Frequently Asked Questions

How soon after diagnosis should treatment start?

Soon enough that the sequence is right. The surgery-versus-chemotherapy decision depends on the resectability assessment, and the maintenance decision depends on genetic results — starting an irreversible step before either is known is the error this pathway exists to prevent. In practice, a complete file is reviewed within 48 hours, the assessment follows within days, and treatment begins promptly after the sequence is set. Sequencing matters more than raw speed.

Can I have a second opinion without travelling first?

Yes, and it is the designed starting point. The complete file — imaging itself, CA-125 trend, pathology, genetic results — is reviewed by a gynaecological oncology MDT remotely, and you receive a written assessment within 48 hours: the likely sequence, whether fertility matters to the plan, what the genotype would change, and what remains to be checked. Travel follows that document, not the other way round.

What does follow-up look like for international patients after flying home?

A written schedule of CA-125 checks, examinations and imaging across the years after treatment, with maintenance therapy — where applicable — managed remotely by the treating team. The schedule is set before departure and the results flow back through the international service, so surveillance does not lapse at a border. For a treatment whose longest phase is home-based tablets, this remote loop is the treatment.

Will treatment cause an early menopause, and what is done about it?

Honestly: usually yes for epithelial disease, because the standard operation removes both ovaries, and chemotherapy advances menopause where it does not cause it. It is managed deliberately rather than endured — hormone therapy discussed case by case, bone and cardiovascular health planned for, and the timing weighed against age and preference before surgery. For fertility-sparing routes the question changes: ovarian function is kept, and the follow-up watches it. Either way, the menopause conversation belongs before the operation, not after.

Patient Stories

Stories from our ovarian cancer programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Start with a written second opinion — no travel needed

Upload the five record items listed above and our gynaecological oncology MDT returns a written assessment within 48 hours: the likely sequence, the role of the genotype, an itemised cost estimate, and what remains to be confirmed before you fly.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*